<div id="readability-page-1"><p>Certara, Inc. (NASDAQ:CERT - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Saturday after Barclays lowered their price target on the stock from $16.00 to $14.00. Barclays currently has an overweight rating on the stock. Certara traded as low as $8.47 and last traded at $8.67, with a volume of 9104388 shares trading hands. The stock had previously closed at $11.27.</p><ul><li>3 Momentum Stocks That Could Soar Post-Market Volatility</li></ul><p>Several other equities analysts also recently weighed in on CERT. Craig Hallum initiated coverage on shares of Certara in a research note on Monday, September 29th. They issued a &#34;buy&#34; rating and a $16.00 target price for the company. Weiss Ratings  reaffirmed a &#34;sell (d)&#34; rating on shares of Certara in a report on Wednesday, October 8th. KeyCorp boosted their target price on shares of Certara from $15.00 to $16.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday, October 8th. Zacks Research upgraded Certara from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Friday, September 5th. Finally, UBS Group reduced their price target on Certara from $17.50 to $15.00 and set a &#34;buy&#34; rating for the company in a research report on Thursday, August 7th. Six equities research analysts have rated the stock with a Buy rating, five have assigned  a Hold rating and one  has issued  a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Hold&#34; and an average target price of $15.38.</p><p><b>Check Out Our Latest Research Report on Certara</b></p><h2>Insider Buying and Selling</h2><ul><li>Simulations Plus Stock Drops 15% Despite EPS Beat</li></ul><p>In other Certara news, insider Leif E. Pedersen sold 51,224 shares of the company's stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $10.92, for a total value of $559,366.08. Following the transaction, the insider directly owned 73,979 shares in the company, valued at $807,850.68. This represents a 40.91% decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. 2.33% of the stock is currently owned by insiders. </p><h2>Institutional Investors Weigh In On Certara</h2><p>A number of institutional investors and hedge funds have recently bought and sold shares of CERT. AdvisorNet Financial Inc purchased a new position in  Certara in the 2nd quarter worth approximately $25,000.  First Horizon Corp bought a new stake in shares of  Certara during the 3rd quarter worth $30,000.  Caitong International Asset Management Co. Ltd purchased a new position in  Certara in the first quarter worth $31,000.  Versant Capital Management Inc increased its stake in  Certara by 66.7% in the third quarter. Versant Capital Management Inc now owns 2,881 shares of the company's stock valued at $35,000 after acquiring an additional 1,153 shares during the last quarter.  Finally, AlphaQuest LLC purchased a new stake in  Certara during the first quarter valued at about $39,000. 73.96% of the stock is owned by hedge funds and other institutional investors. </p><h2>Certara Stock Down 23.1%</h2><ul><li>Are These 3 Small Momentum Stocks Setting Up Big Gains?</li></ul><p>The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.27. The stock has a 50-day simple moving average of $11.77 and a two-hundred day simple moving average of $11.51. The firm has a market cap of $1.39 billion, a PE ratio of 123.86 and a beta of 1.44. </p><p>Certara (NASDAQ:CERT - Get Free Report) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.11 by $0.03. The firm had revenue of $104.62 million for the quarter, compared to analyst estimates of $104.53 million. Certara had a return on equity of 5.17% and a net margin of 2.62%.During the same period in the prior year, the company earned $0.13 EPS.  Certara has set its FY 2025 guidance at 0.450-0.470 EPS. Analysts expect that  Certara, Inc. will post 0.28 earnings per share for the current year. </p><h2>About Certara</h2> (Get Free Report)<p>Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Certara</li><li>What is the Hang Seng index?  </li><li>OpenAI's Restructuring Sets up What Could Be the Biggest IPO Ever</li><li>Stock Market Upgrades: What Are They?</li><li>2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail</li><li>Growth Investing: Should You Adopt This Investing Strategy in 2022?</li><li>CrowdStrike Partners With CoreWeave But Investors Sell the News</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Certara Right Now?</h2><p>Before you consider Certara, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Certara wasn't on the list.</p><p>While Certara currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

CERT

<p>Certara, Inc. (NASDAQ:CERT) reached a new 52-week low of $8.47 after Barclays downgraded its price target from $16.00 to $14.00, maintaining an overweight rating. The stock closed at $8.67, down 23.1%. Analysts have mixed ratings, with six buy, five hold, and one sell. Certara reported a quarterly EPS of $0.14, beating estimates, and set FY 2025 guidance at 0.450-0.470 EPS. Institutional investors hold 73.96% of shares, and insider Leif E. Pedersen sold 51,224 shares recently, reducing his stake by 40.91%.</p>

Certara (NASDAQ:CERT) Reaches New 1-Year Low Following Analyst Downgrade